tert-Butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate

Catalog No. :
ACGXMO299
CAS No. :
939793-20-1
Molecular Formula :
C20H30N2O2
Molecular Weight :
330.47

IUPAC Name:tert-butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate

tert-Butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$820.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate
IUPAC Nametert-butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate
MDL No.MFCD09260614
Molecular FormulaC20H30N2O2
Molecular Weight330.47
SMILESO=C(N(CCC1)CC21CCCN2CC3=CC=CC=C3)OC(C)(C)C
InChI KeyDPSRCYMFYKYHJN-UHFFFAOYSA-N
Synonym1,7-Diazaspiro[4.5]decane-7-carboxylic acid, 1-(phenylMethyl)-, 1,1-diMethylethyl ester;tert-Butyl 1-benzyl-1,7-diazaspiro[4.5]decane-7-carboxylate;7-BOC-1-BENZYL-1,7-DIAZA-SPIRO[4.5]DECANE;1-(phenylmethyl)-1,7-Diazaspiro[4.5]decane-7-carboxylic acid 1,1-dimethylethyl ester
CAS No.939793-20-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGXMO299 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBRSQ283 route compound structure diagram
    ACBRSQ2831187932-79-1 In Stock
  4. Then
  5. ACGXMO299 route product structure diagram
    ACGXMO299939793-20-1
Inquiry

2. ACGXMO299 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRSQ283 route compound structure diagram
    ACBRSQ2831187932-79-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGXMO299 route product structure diagram
    ACGXMO299939793-20-1
Inquiry

Comments (0)